# Galephar Pharmaceutical Research Inc. - Inspection Records

Source: https://www.keypedia.com/companies/galephar-pharmaceutical-research-inc/e38305f7-c401-4d03-8aa7-1f520179a4ea

> Inspection records and compliance data for Galephar Pharmaceutical Research Inc. in Humacao, Puerto Rico. Access full analysis and detailed observations.

---

## Details

- Name: Galephar Pharmaceutical Research Inc.
- FEI Number: 3008206797
- City: Humacao
- State: Puerto Rico
- Country Name: United States
- Address Line 1: Rd 925 Km 6.1 Bo Junquito
- Zip Code: 00741

## Related Documents

- [CRL - Galephar Pharmaceutical Research Inc. - Unknown Date](https://www.keypedia.com/records/crl/galephar-pharmaceutical-research-inc/23c59f5c-eb17-44d3-a3d9-da1897b48d9d) — source: FDA, date: Invalid Date
- [FDA Inspection 1273815 - Galephar Pharmaceutical Research Inc. - 2025-06-05](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/2815fac7-3c9a-4abc-a063-baf2b2f01282) — source: FDA, date: June 5, 2025
- [FDA Inspection 1273815 - Galephar Pharmaceutical Research Inc. - 2025-06-05](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/d8cdab26-f62d-471e-b6a2-da022fbc3b33) — classification: No Action Indicated (NAI), source: FDA, date: June 5, 2025
- [FDA Inspection 1273815 - Galephar Pharmaceutical Research Inc. - 2025-06-05](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/38bcab3a-e5b9-49c5-8833-2a2cb1d46fc6) — classification: No Action Indicated (NAI), source: FDA, date: June 5, 2025
- [483 - Galephar Pharmaceutical Research Inc. - 2023-01-20](https://www.keypedia.com/records/483/galephar-pharmaceutical-research-inc/31af354d-f774-40f1-96f0-5d6b7e534577) — source: FDA, date: January 20, 2023
- [FDA Inspection 1195423 - Galephar Pharmaceutical Research Inc. - 2023-01-20](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/59927c3c-8982-49d0-beb5-61192989019d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 20, 2023
- [FDA Inspection 1108270 - Galephar Pharmaceutical Research Inc. - 2019-11-01](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/49cc3d4f-72d6-411a-9030-98429f83dbc9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 1, 2019
- [FDA Inspection 931265 - Galephar Pharmaceutical Research Inc. - 2015-06-11](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/425adf79-22da-4d9b-8de8-1e88f02e3e5c) — classification: No Action Indicated (NAI), source: FDA, date: June 11, 2015
- [FDA Inspection 931265 - Galephar Pharmaceutical Research Inc. - 2015-06-11](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/b69ab604-9aad-46a9-8cd3-e8d02eeacef6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 11, 2015
- [FDA Inspection 814051 - Galephar Pharmaceutical Research Inc. - 2013-01-15](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/1695c2ee-2d10-4e34-b5fe-286c12fdbb32) — classification: No Action Indicated (NAI), source: FDA, date: January 15, 2013
- [FDA Inspection 776879 - Galephar Pharmaceutical Research Inc. - 2012-05-07](https://www.keypedia.com/records/fda_inspections/galephar-pharmaceutical-research-inc/d8a73403-13a9-4e31-9012-9bf11889f6a3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 7, 2012

## Related Companies

- [Ex-Lax, Inc.](https://www.keypedia.com/companies/ex-lax-inc/cfc25b6c-4013-44bd-ab11-7088e88f0327)
- [Tapi Puerto Rico, Inc.](https://www.keypedia.com/companies/tapi-puerto-rico-inc/ad452651-30ba-4a62-960f-cfe8d9cd2352)
- [Colorcon P.R., LLC](https://www.keypedia.com/companies/colorcon-pr-llc/e2b504df-c1e5-44da-ba92-4f945950f24d)
- [Banco De Sangre Humacao, Inc.](https://www.keypedia.com/companies/banco-de-sangre-humacao-inc/a38577a1-d289-4fff-a8f8-a1b9bb9ec196)
- [Bristol-Myers Squibb Manufacturing Company Unlimited Company](https://www.keypedia.com/companies/bristol-myers-squibb-manufacturing-company-unlimited-company/ccfba5f2-eeac-4000-bb3a-437eefc63c7c)
- [Linde Puerto Rico B.V.](https://www.keypedia.com/companies/linde-puerto-rico-bv/0d384043-b510-4766-91c8-ed12a66e99fc)
- [FILOP CORP](https://www.keypedia.com/companies/filop-corp/93abd3fe-9103-45d2-a29a-6a1e1a827b8d)
- [Cardona Compounds Corp.](https://www.keypedia.com/companies/cardona-compounds-corp/3a188439-874c-45ca-af61-88f43fa08afc)
- [Legacy Pharmaceuticals Puerto Rico, LLC](https://www.keypedia.com/companies/legacy-pharmaceuticals-puerto-rico-llc/58156a9a-858f-4668-ad4b-37c8d07f5dc0)
- [Syntex Puerto Rico, Inc.](https://www.keypedia.com/companies/syntex-puerto-rico-inc/f504b496-9994-49c0-a967-15ba64e8bded)

## Related Officers

- [Britta Martinez](https://www.keypedia.com/people/britta-martinez/2472927d-8261-4173-8931-5dbc129a59a1)